Tony Melarangi PhD
Senior Cell Scientist
Tony Melarangi has significant experience from many years working in the biopharmaceutical industry, mainly focused on Upstream process development.
More about Tony
Tony Melarangi joined Sygnature after spending over 8 years in upstream process development, scale-up and tech transfer at a biologics site in Liverpool. He worked on gene therapy, plasmid and antibody projects using a range of cell types and bioreactor platforms.
Tony's prior experience includes the generation and characterisation of cardiomyocytes featuring variants of the β2-Adrenoceptor within a stem cell group at the University of Nottingham, and haemato-oncology research at the University of Liverpool, where he completed his PhD in Glucocorticoid resistance in Chronic Lymphocytic Leukaemia.
Tony enjoys cycling and bouldering, reading history, and tries to produce new music from time to time using instruments in which he has varying degrees of proficiency.
Cell Science Team
